Martek Biosciences (MATK) Tops Q2 EPS by 4c; Guides
Tweet Send to a Friend
Martek Biosciences Corporation (Nasdaq: MATK) reports Q2 EPS of $0.33, 4 cents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
